Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
- 9 June 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (2), 459
- https://doi.org/10.1016/j.kint.2021.06.005
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Minimal Change Disease Following the Pfizer-BioNTech COVID-19 VaccineAmerican Journal of Kidney Diseases, 2021
- Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccineKidney International, 2021
- Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021
- Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccinationBMC Nephrology, 2009
- Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndromeThe Lancet, 2003
- Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccineClinical Nephrology, 2002
- Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination.2000